Literature DB >> 3762511

Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis.

H E Gruber, J L Ivey, E R Thompson, C H Chesnut, D J Baylink.   

Abstract

This study evaluates osteoblast and osteoclast cell numbers and cell activities determined from quantitative histology of trabecular bone in human iliac crest bone biopsies. Subjects studied were postmenopausal osteoporotic patients (aged 53-81) for whom total body calcium and urine and serum clinical data were also available. Only 39% of the osteoclasts identified by acid phosphatase content were multinucleate; however, a significant correlation between multinucleate osteoclasts and the total number of osteoclasts was found (r = 0.87; p less than 0.001). The mean number of osteoclasts per square millimeter of total tissue area was 0.96 (+/- 0.14, SEM, n = 36); the mean number of osteoblasts was 6.8 (+/- 1.5, n = 14)/mm2 tissue area. Computed osteoclast activity (square millimeter bone resorbed per osteoclast nucleus per day) was 2.6 X 10(-4) +/- 1.0 X 10(-4) (n = 13). Computed osteoblast activity (square millimeter bone formed per osteoblast per day) was 2.9 X 10(-5) +/- 8.8 X 10(-6) (n = 13). Calculated mean rate of bone resorption was 1.6 X 10(-4) +/- 3.4 X 10(-5) mm2 bone resorbed per mm2 total tissue area per day (n = 19). These data indicate that although osteoclasts are not numerous in the iliac crest of postmenopausal osteoporotics, the individual osteoclast activity (in square millimeter bone resorbed osteoclast cell unit per day) is significantly greater (p less than 0.001) than the osteoblast activity (in square millimeter matrix deposited per cell per day). These data also point out that greater consideration should be given to the role that osteoclast cell activity may play in human postmenopausal osteoporosis.

Entities:  

Mesh:

Year:  1986        PMID: 3762511

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  17 in total

1.  Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.

Authors:  W He; B N Cronstein
Journal:  Purinergic Signal       Date:  2012-02-05       Impact factor: 3.765

2.  Conditional Disruption of miR17~92 in Osteoclasts Led to Activation of Osteoclasts and Loss of Trabecular Bone In Part Through Suppression of the miR17-Mediated Downregulation of Protein-Tyrosine Phosphatase-oc in Mice.

Authors:  Kin-Hing William Lau; Virginia M Stiffel; Charles H Rundle; Mehran Amoui; Jordan Tapia; Tyler D White; Matilda H-C Sheng
Journal:  JBMR Plus       Date:  2017-08-01

Review 3.  Phosphotyrosyl protein phosphatases.

Authors:  K H Lau; J R Farley; D J Baylink
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

4.  Prevention of alveolar bone loss in an osteoporotic animal model via interference of semaphorin 4d.

Authors:  Y Zhang; L Wei; R J Miron; Q Zhang; Z Bian
Journal:  J Dent Res       Date:  2014-09-24       Impact factor: 6.116

5.  Detection and characterization of endothelin in transformed human osteoblast cell culture medium.

Authors:  H C Lam; J K Lee; K H Lai
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

6.  Bone histology in young adult osteoporosis.

Authors:  E Hills; C R Dunstan; S Y Wong; R A Evans
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

7.  Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.

Authors:  J R Farley; S L Hall; N M Tarbaux
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

8.  Temporal relationship between bone loss and increased bone turnover in ovariectomized rats.

Authors:  T J Wronski; M Cintrón; L M Dann
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

9.  Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients.

Authors:  R D Hesch; U Busch; M Prokop; G Delling; E F Rittinghaus
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

10.  In vitro evidence that local and systemic skeletal effectors can regulate 3[H]-thymidine incorporation in chick calvarial cell cultures and modulate the stimulatory actions(s) of embryonic chick bone extract.

Authors:  J R Farley; N M Tarbaux; J P Vermeiden; D J Baylink
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.